Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

10.11.2015 - 11.11.2015

6th International Fresenius Conference: Endocrine Disruptors

Location
Köln
Contact

Anja Staudenmaier
Konferenz Managerin und Akademieleitung
Telefon  +49 231 75896-54
fresenius@akademie-fresenius.de

Annika Koterba
Veranstaltungsorganisation
Telefon  +49 231 75896-74
Telefax  +49 231 75896-53
akoterba@akademie-fresenius.de

Country
Germany
Subject area(s)
Shortinfo

Veranstaltungsort


Park Inn by Radisson Köln City West
Innere Kanalstraße 15
50823 Köln
Germany
Telefon  +49 221 5701-0
Telefax  +49 221 5701-999
koeln@proventhotels.com
www.pikcw.de

Themen:

Impact assessment – cost and benefits

  • Burden of disease and costs of endocrine disrupting chemicals in the European Union
  • Update from the European Commission on the ongoing impact assessment
  • Industry view on latest developments in the endocrine disruptors impact assessment



Evidence

  • Translating science to improve public health – new tools in epidemiology
  • Concerns over low dose/thresholds/NMDRC in endocrine disruption
  • Weight of evidence approach with some endocrine disruptor compounds



Regulatory update

  • References to EDs in EU Law
  • ECHA Report on the restriction process under Reach for endocrine active substances
  • Identification of EDs as SVHC



Assessment

  • The OECD conceptual framework for testing for endocrine effects
  • EDSP List 1 Chemicals: assays results and WOE determinations



Adverse Outcome Pathways

  • Adverse outcome pathways: a conceptual framework
  • Endocrine disruptor related AOP development: OECD and ECETOC activities